| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 66151 |
DPPE，cas:923-61-5，磷脂酰乙醇胺，1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine |
158 |
axc |
2025-01-02 |
| 66152 |
P-LysoPC，cas:17364-16-8，1-十六酰-sn-丙三醇-磷酸胆碱 |
113 |
axc |
2025-01-02 |
| 66153 |
DLPC，cas:18194-25-7，1,2-二月桂酰基-sn-glycero-3-胆碱磷酸 |
77 |
axc |
2025-01-02 |
| 66154 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes，HSPC/Chol/DSPE-mPEG2000/MPL脂质体 |
89 |
axc |
2024-12-31 |
| 66155 |
DOTAP/DOPE (50/50, mol/mol) Liposomes，DOTAP/DOPE (50/50，摩尔/摩尔)脂质体 |
106 |
axc |
2024-12-31 |
| 66156 |
Adavosertib Liposomes, Formulation WD4，阿达沃塞替布脂质体，制剂WD4 |
266 |
axc |
2024-12-31 |
| 66157 |
Mirdametinib (PD0325901) Liposomes, Formulation U6-2，Mirdametinib (PD0325901)脂质体，配方U6-2 |
154 |
axc |
2024-12-31 |
| 66158 |
DT-061 (SMAP) Liposomes, Formulation TT-40，DT-061 (SMAP)脂质体，制剂TT-40 |
101 |
axc |
2024-12-31 |
| 66159 |
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1，坦那霉素(17-AAG)脂质体，配方XT28.1 |
101 |
axc |
2024-12-31 |
| 66160 |
Nexturastat A Liposomes，Nexturastat A脂质体，靶向脂质体定制服务 |
97 |
axc |
2024-12-31 |
| 66161 |
A939572 Liposomes，A939572脂质体，靶向脂质体定制服务 |
122 |
axc |
2024-12-31 |
| 66162 |
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2，Eganelisib (IPI-549)脂质体，制剂WNX5.2 |
161 |
axc |
2024-12-31 |
| 66163 |
Lificiguat (YC-1) Liposomes, Formulation FNT8P.2，Lificiguat (YC-1)脂质体，制剂FNT8P.2 |
85 |
axc |
2024-12-31 |
| 66164 |
SP600125 Liposomes, Formulation HZ12，SP600125脂质体，配方HZ12 |
99 |
axc |
2024-12-31 |
| 66165 |
Rocaglamide Liposomes, Formulation KHE9A，罗卡酰胺脂质体，配方KHE9A |
98 |
axc |
2024-12-31 |
| 66166 |
Gilteritinib (ASP2215) Liposomes，吉尔替尼(ASP2215)脂质体 |
90 |
axc |
2024-12-31 |
| 66167 |
CAS:125503-35-7 双(2,5-二氧吡咯烷-1-基)2,2'-(丙烷-2,2-二基双(磺胺基)二乙酸酯) |
115 |
zhn |
2024-12-31 |
| 66168 |
AZD1208 Liposomes, Formulation RB4T4，AZD1208脂质体，配方RB4T4 |
68 |
axc |
2024-12-31 |
| 66169 |
DiR Labeled Tumor-Accumulating Liposomes邃，DiR标记的肿瘤积聚脂质体 |
94 |
axc |
2024-12-31 |
| 66170 |
氧化锌量子点（ZnO QDs） 无机半导体材料 |
181 |
zhn |
2024-12-31 |
| 66171 |
聚多巴胺微球 |
173 |
zhn |
2024-12-31 |
| 66172 |
PS-R-PMMA 聚苯乙烯（PS）和聚甲基丙烯酸甲酯（PMMA）共聚物 |
294 |
zhn |
2024-12-31 |
| 66173 |
AgBiS₂量子点 银铋硫化物量子点 |
120 |
zhn |
2024-12-31 |
| 66174 |
单层石墨相氮化碳纳米片（Graphitic Carbon Nitride, g-C₃N₄） |
241 |
zhn |
2024-12-31 |
| 66175 |
HSPC/胆固醇/DSPE-mPEG2000 (56.2/38.5/5.3，摩尔/摩尔)脂质体(DiD标记)，脂质体定制服务 |
121 |
axc |
2024-12-31 |
| 66176 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes (DiD-labeled)，脂质体定制服务 |
127 |
axc |
2024-12-31 |
| 66177 |
环糊精修饰螺吡类分子 |
83 |
zhn |
2024-12-31 |
| 66178 |
HSPC/胆固醇/DSPE-聚乙二醇2000/DSPE-聚乙二醇2000-马来酰亚胺(50/45/4/1，摩尔/摩尔)脂质体，脂质体定制服务 |
119 |
axc |
2024-12-31 |
| 66179 |
二氧化硅包纳米金棒 SiO₂@Au nanorods |
102 |
zhn |
2024-12-31 |
| 66180 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes，脂质体定制服务 |
125 |
axc |
2024-12-31 |
| 66181 |
四氧化三铁二硫化钼复合材料 Fe₃O₄@MoS₂ |
226 |
zhn |
2024-12-31 |
| 66182 |
17-(Azide-PEG9-ethylcarbamoyl)heptadecanoic t-butyl ester |
80 |
h |
2024-12-31 |
| 66183 |
14-(Azide-PEG6-ethylcarbamoyl)tridecanoic-t-butyl ester |
72 |
h |
2024-12-31 |
| 66184 |
IR-700-NH2 氨基化的近红外荧光染料 |
167 |
zhn |
2024-12-31 |
| 66185 |
HSPC/Chol/DSPE-mpeg 2000/DSPE-mpeg 2000-马来酰亚胺/MPL (49/45/4/1/1，摩尔/摩尔)脂质体，脂质体定制服务 |
87 |
axc |
2024-12-31 |
| 66186 |
14-(Azide-PEG4-ethylcarbamoyl)tridecanoic-t-butyl ester |
85 |
h |
2024-12-31 |
| 66187 |
Amine-PEG5-c18-t-butyl ester |
139 |
h |
2024-12-31 |
| 66188 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide/MPL(49/45/4/1/1, mol/mol) Liposomes，脂质体定制服务 |
144 |
axc |
2024-12-31 |
| 66189 |
PS22500-EHA100000-PS22500 一种嵌段共聚物 |
89 |
zhn |
2024-12-31 |
| 66190 |
16-(Amine-PEG3-ethylcarbamoyl)pentadecanoic-t-butyl ester |
116 |
h |
2024-12-31 |
| 66191 |
PCN-224 金属有机骨架 |
554 |
zhn |
2024-12-31 |
| 66192 |
17-(Bromoacetamido-PEG9-ethylcarbamoyl)tridecanoic t-butyl ester |
62 |
h |
2024-12-31 |
| 66193 |
DOPC Liposomes，DOPC脂质体，二油酰基磷脂酰胆碱脂质体 |
181 |
axc |
2024-12-31 |
| 66194 |
DSPC Liposomes，DSPC脂质体，二硬脂酰磷脂酰胆碱脂质体 |
171 |
axc |
2024-12-31 |
| 66195 |
14-(Bromoacetamido-PEG6-ethylcarbamoyl)tridecanoic t-butyl ester |
61 |
h |
2024-12-31 |
齐岳微信公众号
官方微信
库存查询